Quick Takeaways
- ALGER ASSOCIATES INC filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock (FBRX).
- Disclosed ownership: 18%.
- Date of event: 31 Dec 2024.
ALGER ASSOCIATES INC - 31 Dec 2024 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock (FBRX)
- Filing Manager
- ALGER ASSOCIATES INC
- Reporting Manager
- Alger Associates, Inc. 13-3017981
- Security
- Forte Biosciences, Inc. Common Stock
- Symbol
- FBRX
- Shares outstanding
- 6,406,463 shares
- Disclosed Ownership
- 1,133,944 shares
- Ownership
- 18%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 17:18:05 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ALGER ASSOCIATES INC disclosed 18% ownership in Forte Biosciences, Inc. Common Stock (FBRX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 17:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alger Associates, Inc. 13-3017981 | 18% | 1,133,944 | 1,112,322 | 0 | /s/ Hal Liebes | Hal Liebes / Secretary |